Figure 5From: Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept Distant progression-free survival. DPFS was 93,3% after 36 months and 83,3% after 60 months with no further recurrences after 43 months (Kaplan-Meier, n = 20).Back to article page